GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health ...

Patterns differ among medication classes; potential mechanisms need more research ...

Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are ...

Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...

Fascinating nervous system imaging reveals previously unseen obesity-related nerve damage in mice and humans — and some of it ...

A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated ...

A new study suggests GLP-1 medications, such as semaglutide, were associated with better overall outcomes in people with type ...

For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...

Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with patients ...

GLP-1 receptor agonist drugs, used for the treatment of diabetes, and more recently, weight loss, are associated with a significantly lower long term risk of knee replacement surgery as a result ...